We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Overactive Transcription Factor Transforms Normal Epithelial Cells into Tumors

By LabMedica International staff writers
Posted on 15 Nov 2010
The Sp2 transcription factor, which is overexpressed in many types of human cancer, has been definitively linked to the transformation of epithelial cells into cancer cells in a transgenic mouse model.

Sp proteins are evolutionarily conserved transcription factors required for the expression of a wide variety of genes that are critical for development and cell-cycle progression. More...
Deregulated expression of certain Sp proteins has been shown to be associated with the formation of a variety of human tumors. However, direct evidence linking a specific Sp protein to development of cancer has been lacking.

In the current study, investigators at North Carolina State University (Raleigh, NC, USA) worked with a transgenic mouse model in which animals were either hemizygous or homozygous for the Sp2 gene.

The investigators reported in the November 1, 2010, issue of the journal Cancer Research that overexpression of Sp2 in epidermal basal keratinocytes caused these cells to stop producing differentiated cells and instead to reproduce as undifferentiated (stem cells) cells that eventually progressed to a tumor. Transgenic animals that were homozygous rather than hemizygous for the Sp2 transgene exhibited a striking arrest in the epidermal differentiation program, perishing within two weeks of birth.

"Something happens to normal stem cells that changes the way SP2 is regulated, and it starts being overproduced,” said senior author Dr. Jon Horowitz, associate professor of molecular biomedical sciences at North Carolina State University. "SP2 basically hijacks the stem cell, and turns it into its evil twin – a cancer cell. Our hope is that we can find an "antidote” to SP2, to restore normal cell proliferation to those cancer stem cells and reverse the process.”

Related Links:

North Carolina State University



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.